The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans
Open accessAbstract
Contrary to many other viruses, the initial steps of the hepatitis B virus (HBV) infection, including attachment to hepatocytes, specific receptor interactions, and membrane fusion, are unsolved. Using HepaRG cells as an in vitro cell culture system, we here report that HBV entry into hepatocytes depends on the interaction with the glycosaminoglycan (GAG) side chains of cell-surface–associated heparan sulfate proteoglycans. Binding to GAGs requires the integrity of the pre-S domain as a part of the large (L-) viral envelope protein. HBV infection was abrogated by incubation of virions with heparin, but not the structurally related GAGs chondroitin sulfate A, B, and C. Infection was also abolished by suramin, a known inhibitor of duck hepatitis B virus infection or highly sulfated dextran sulfate. Polycationic substances such as poly-l-lysine, polybrene, and protamine also prevented infection, however, by addressing cellular components. Enzymatic removal of defined acidic carbohydrate structures from the cell surface using heparinase I/III or the obstruction of GAG synthesis by sodium chlorate inhibited HBV infection of HepaRG cells and, moreover, led to a reduction of HBV cell surface binding sites. The biochemical analysis showed selective binding of L-protein–enriched viral particles (virions or filaments) to heparin. GAG-dependent binding of HBV was improved by polyethylene glycol, a substance that specifically enhances HBV infection. Conclusion: HBV infection requires the initial attachment to the carbohydrate side chains of hepatocyte-associated heparan sulfate proteoglycans as attachment receptors. This interaction initializes the multistep entry process of HBV and cannot be bypassed by alternative routes. (Hepatology 2007;46:1759–1768.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological roles of oligosaccharides: all of the theories are correct
Varki, A. (1993) · Glycobiology · doi:10.1093/glycob/3.2.97 · Cited by 5,195
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Self-citationHepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,148
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
WuDunn, D., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.52-58.1989 · Cited by 919
Large surface proteins of hepatitis B virus containing the pre-s sequence
Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H., & Gerlich, W. H. (1984) · Journal of Virology · doi:10.1128/jvi.52.2.396-402.1984 · Cited by 823
Animal cell mutants defective in glycosaminoglycan biosynthesis.
Esko, J. D., Stewart, T. E., & Taylor, W. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3197 · Cited by 513
Chlorate — a potent inhibitor of protein sulfation in intact cells
Baeuerle, P. A., & Huttner, W. B. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80253-4 · Cited by 349
Gripon, P., Cannie, I., & Urban, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1613-1622.2005 · Cited by 347
Self-citationViral and cellular determinants involved in hepadnaviral entry
Glebe, D. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.22 · Cited by 285
Cited by
Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., et al. (2012) · eLife · doi:10.7554/elife.00049 · Cited by 2,115
Ni, Y., Lempp, F. A., Mehrle, S., Nkongolo, S., Kaufman, C., Fälth, M., Stindt, J., Königer, C., Nassal, M., Kubitz, R., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.024 · Cited by 781
Self-citationLiving in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H., & Dusheiko, G. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-19 · Cited by 554
Immunobiology and pathogenesis of hepatitis B virus infection
Iannacone, M., & Guidotti, L. G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00549-4 · Cited by 520
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Tu, T., Budzinska, M., Shackel, N., & Urban, S. (2017) · Viruses · doi:10.3390/v9040075 · Cited by 447
Self-citationInhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023710 · Cited by 427
Role of liver sinusoidal endothelial cells in liver diseases
Gracia-Sancho, J., Caparrós, E., Fernández-Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 410
Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
Self-citationHepatitis B virus biology and life cycle
Tsukuda, S., & Watashi, K. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104925 · Cited by 376
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.030 · Cited by 361
Self-citationIwamoto, M., Watashi, K., Tsukuda, S., Aly, H. H., Fukasawa, M., Fujimoto, A., Suzuki, R., Aizaki, H., Ito, T., Koiwai, O., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.052 · Cited by 321
Present and future therapies of hepatitis B: From discovery to cure
Liang, T. J., Block, T. M., McMahon, B. J., Ghany, M. G., Urban, S., Guo, J., Locarnini, S., Zoulim, F., Chang, K., & Lok, A. S. (2015) · Hepatology · doi:10.1002/hep.28025 · Cited by 317
Self-citationThe hepatitis delta virus: Replication and pathogenesis
Sureau, C., & Negro, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.013 · Cited by 276
Watashi, K., Sluder, A., Daito, T., Matsunaga, S., Ryo, A., Nagamori, S., Iwamoto, M., Nakajima, S., Tsukuda, S., Borroto-Esoda, K., et al. (2014) · Hepatology · doi:10.1002/hep.26982 · Cited by 266
Lipid-based nanoparticle technologies for liver targeting
Böttger, R., Pauli, G., Chao, P.-H., AL Fayez, N., Hohenwarter, L., & Li, S.-D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.017 · Cited by 264
Yan, H., Peng, B., Liu, Y., Xu, G., He, W., Ren, B., Jing, Z., Sui, J., & Li, W. (2014) · Journal of Virology · doi:10.1128/jvi.03478-13 · Cited by 263
Zeisel, M. B., Lucifora, J., Mason, W. S., Sureau, C., Beck, J., Levrero, M., Kann, M., Knolle, P. A., Benkirane, M., Durantel, D., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308943 · Cited by 256
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
New Applications of Heparin and Other Glycosaminoglycans
Lima, M., Rudd, T., & Yates, E. (2017) · Molecules · doi:10.3390/molecules22050749 · Cited by 89
Natural history of chronic hepatitis B virus infection.
Busch, K., & Thimme, R. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0369-7 · Cited by 68
A decade of liver organoids: Advances in disease modeling
Liu, Y., Sheng, J.-Y., Yang, C.-F., Ding, J., & Chan, Y.-S. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0428 · Cited by 30
Hepatitis B virus receptors and molecular drug targets
Verrier, E. R., Colpitts, C. C., Sureau, C., & Baumert, T. F. (2016) · Hepatology International · doi:10.1007/s12072-016-9718-5 · Cited by 25
Metadata
- Authors
- Schulze, A., Gripon, P., & Urban, S.
- Venue
- Hepatology
- Published
- 2007-12
- Volume
- 46
- Issue
- 6
- Pages
- 1759-1768
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2002969023
- Cited by
- 445
- References
- 33
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.